MYNZ — Mainz Biomed NV Cashflow Statement
0.000.00%
Last trade - 00:00
- $7.64m
- $6.96m
- $0.90m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.957 | -0.587 | -11.7 | -26.4 | -26.3 |
Depreciation | |||||
Non-Cash Items | 0.064 | 0 | 8.54 | 9.85 | 3.56 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.423 | 0.058 | -0.139 | 1.39 | -0.065 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.416 | -0.469 | -3.22 | -14.8 | -21.9 |
Capital Expenditures | 0 | -0.01 | -0.017 | -0.658 | -1.9 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | 1.22 | — | — |
Sale of Business | |||||
Cash from Investing Activities | 0 | -0.01 | 1.2 | -0.658 | -1.9 |
Financing Cash Flow Items | 0 | 0.399 | 0.244 | 0 | -0.934 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.424 | 0.397 | 10.6 | 23.9 | 14.2 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.026 | -0.081 | 8.6 | 8.41 | -10.1 |